Sign in

Private company

BioKey (Cayman), Inc.

BioKey (Cayman), Inc. is a pharmaceutical preparations company in the Cayman Islands.1 It is headquartered in Fremont, California.1

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersFremont, California1
  • Incorporated inCayman Islands2
  • Business address44370 Old Warm Springs Blvd, Fremont, Ca 945382
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Corporate structure

BioKey (Cayman), Inc. is part of a group headed by ABVC BIOPHARMA, INC.. 9 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • ABVC BIOPHARMA, INC. Fremont, California
    • BioKey (Cayman), Inc. Fremont, California
    • AiBtl BioPharma Inc. Subsidiary · Delaware, United States
    • American BriVision Corporation Subsidiary · Delaware, United States
    • BioKey, Inc. Subsidiary · California, United States
    • BioLite BVI, Inc. Subsidiary · British Virgin Islands
    • BioLite Holding, Inc. Subsidiary · Nevada, United States
    • BioLite, Inc. Subsidiary · Taiwan
    • Yunzhiyi Co., Ltd. Subsidiary · Taiwan

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Timeline

  1. Aug 27, 20268-K Entered a material agreement; Regulation FD disclosure3
  2. Aug 27, 20268-K Financial statements and exhibits4
  3. Aug 7, 20268-K Change of auditor5
  4. Aug 6, 20268-K Change of auditor6
  5. Aug 5, 20268-K Other events7

Filings

11 filings to the SEC since October 2021: 1 quarterly reports, 5 major events, 5 other. The latest 11:

  1. Aug 27, 20268-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
  2. Aug 27, 20268-K CURRENT REPORT EDGAR
  3. Aug 20, 202610-Q QUARTERLY REPORT EDGAR
  4. Aug 14, 2026NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  5. Aug 7, 20268-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
  6. Aug 6, 20268-K CURRENT REPORT EDGAR
  7. Aug 5, 20268-K CURRENT REPORT EDGAR
  8. Jun 25, 2026SEC STAFF ACTION EDGAR
  9. Jun 22, 202610-12G/A AMENDMENT NO. 1 TO FORM 10-12G EDGAR
  10. May 28, 202610-12G GENERAL FORM FOR REGISTRATION OF SECURITIES EDGAR
  11. Feb 11, 2026DRS EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How BioKey (Cayman), Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBioKey (Cayman), Inc.1
  • CIK0002108359
  • Filer status<br>emerging growth company1
  • Incorporated inCayman Islands1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address44370 Old Warm Springs Blvd, Fremont, CA 945381
  • Phone(510) 668-08811
  • Shares outstanding30,000,000 as of Aug 19, 20268
  • On EDGAR sinceFeb 11, 20261
  • Filings11 in all: 8-K (3), 8-K/A (2), 10-12G (1), 10-12G/A (1), 10-Q (1), DRS (1), NT 10-Q (1), SEC STAFF ACTION (1)1
  • Latest filingsQuarterly report (10-Q) Aug 20, 2026
    Latest 8-K (8-K) Aug 27, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    SEC EDGAROther events
  8. 8